Izon Science to sponsor Sydney 2010 International Nanomedicine Conference
Christchurch, New Zealand, Tuesday 29 June 2010 - New Zealand based nanotechnology company Izon Science, today announced its sponsorship and participation in the
Sydney 2010 International Nanomedicine Conference. The three day nanomedicine conference, to be held 30 June to 2 July,
will bring together researchers and developers from around the world working in targeted delivery, diagnostics and
regenerative medicine.
"We're delighted to be a sponsor. Nanomedicine is an extremely exciting and important field. It has the potential to
enable early detection and prevention, and to dramatically improve diagnosis, treatment and follow-up of diseases. By
collaborating with researchers through forums like this we can continue to develop world leading technology that will
help break new ground in healthcare", says Hans van der Voorn, the Executive Chairman of Izon.
Izon's qNano and qViro instruments combined with the newly launched Variable Pressure Module (VPM) provide the world's
most comprehensive nanoparticle analysis system.
As part of the sponsorship package Izon is donating a major prize for a fundraising event at the conference to benefit
the Children's Cancer Institute Australia. The prize package includes the use of a qNano for one year, with consumables,
along with full training in New Zealand and support by Izon technical staff and the travel package to New Zealand.
Researchers using Izon's nanoparticle analysis system can measure and characterize virtually all particles including
nanoparticles, viruses, bacteria and bioparticles such as exosomes and liposomes. Particle concentration,
electrophoretic mobility, size and aggregation kinetics can all be analysed. Real time reaction monitoring allows users
to design and test nanoparticle systems by analyzing the changes in particle properties as various modifications are
applied. This is useful for bio-nano work, drug delivery research or development of diagnostic applications.
Izon's instruments are used across a wide range of scientific fields including nanomedicine, bionanotechnology,
virology, vaccinology, microbiology, gene therapy, medical research, marine science, aquaculture, chemistry and
nanoscience. Current projects include virus quantitation and analysis, oncolytic viruses, marine science, drug delivery
systems, nanoparticle charge measurement, diagnostic applications using antibodies and nanoparticles, bioparticle
analysis, and controlled dispensing of particles and biomolecules by count.
The Sydney 2010 International Nanomedicine Conference will be held at the Crowne Plaza Coogee Beach in Sydney. Izon
Chairman Hans van der Voorn will deliver a brief presentation at the conference dinner on Friday 2 July.
ENDS